The USP13 inhibitor Spautin-1 induced ferroptosis in DLBCL through the regulation of NF-κB and Notch signaling and well synergized with conventional DLBCL chemo-agents, validated by both in-vivo and in-vitro experiments. The gene discussed is NFKB1; the disease is diffuse large B-cell lymphoma.